Yantiss, Rhonda K.
University of Miami Leonard M. Miller School of Medicine,
United States
2025 Rank: 73465
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 108 out of 25326 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73465 | 72330 |
| Total Cites | 669 | 750 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 17 | 18 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 80 | 84 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 243 | 259 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 595 | 643 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.17 |
| Self-Citation Percentage |
10.80%
|
|
Yantiss, Rhonda K.
University of Miami Leonard M. Miller School of Medicine,
United States
2024 Rank: 79161
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 121 out of 24457 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79161 | 80030 |
| Total Cites | 645 | 723 |
| H-index | 12 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 81 | 81 |
| Number of Single+First+Last Authored Papers | 99 | 99 |
| Total Cites to Single+First+Last Authored Papers | 232 | 239 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 605 | 656 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.10 |
| Self-Citation Percentage |
10.79%
|
|
Yantiss, Rhonda K.
Weill Cornell Medicine,
United States
2023 Rank: 72630
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 138 out of 23576 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72630 | 74425 |
| Total Cites | 623 | 700 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 97 | 105 |
| Number of Single+First+Last Authored Papers | 98 | 98 |
| Total Cites to Single+First+Last Authored Papers | 233 | 253 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 550 | 590 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.19 |
| Self-Citation Percentage |
11.00%
|
|
Yantiss, Rhonda K.
Weill Cornell Medicine,
United States
2022 Rank: 69008
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 119 out of 23010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69008 | 73667 |
| Total Cites | 586 | 637 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 95 | 95 |
| Number of Single+First+Last Authored Papers | 88 | 88 |
| Total Cites to Single+First+Last Authored Papers | 235 | 237 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 528 | 565 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
8.01%
|
|
Yantiss, Rhonda K.
Weill Cornell Medicine,
United States
2021 Rank: 74326
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 131 out of 22656 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74326 | 73832 |
| Total Cites | 815 | 1000 |
| H-index | 13 | 15 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 13 | 14 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 141 | 145 |
| Number of Single+First+Last Authored Papers | 84 | 84 |
| Total Cites to Single+First+Last Authored Papers | 367 | 386 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 707 | 777 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.29 |
| Self-Citation Percentage |
18.50%
|
|
Yantiss, Rhonda K.
Weill Cornell Medicine,
United States
2020 Rank: 101021
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 174 out of 19713 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 101021 | 107174 |
| Total Cites | 516 | 555 |
| H-index | 12 | 12 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 6 | 7 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 98 | 102 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 244 | 260 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 468 | 496 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
7.03%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.